K. Angela Macfarlane
CIK: 0001865182
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RenovoRx, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Oct 1, 2026RNXT
RenovoRx, Inc.
Award(A)DirectStock Options (right to buy)
55.9K shares- - Oct 1, 2025RNXT
RenovoRx, Inc.
Award(A)DirectStock Options (right to buy)
47.6K shares- - Oct 1, 2024RNXT
RenovoRx, Inc.
Award(A)DirectStock Options (right to buy)
25.1K shares-
1-3 of 3 transactions
About Macfarlane K. Angela
Macfarlane K. Angela (SEC CIK 0001865182) files insider reports with the SEC as Director of RenovoRx, Inc. (RNXT).
Signal8 holds 3 ownership filings by Macfarlane K. Angela, all Form 4s, filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 3 transactions, from Oct 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Macfarlane K. Angela's filings is in MOUNTAIN VIEW, CA.
Recent filings by Macfarlane K. Angela
Other insiders filing for RenovoRx, Inc. (RNXT)
- Spiegel Robert J., Director
- RYAN UNA S, Director
- Marton Laurence, Director
- VOLL MARK, Chief Financial Officer
- Bagai Shaun, Chief Executive Officer
- Gentry Leesa, Chief Clinical Officer